Updated ESH position paper on interventional therapy of resistant hypertension.

Roland E. Schmieder, Josep Redon, Guido Grassi, Sverre E. Kjeldsen, Giuseppe Mancia, Krzysztof Narkiewicz, Gianfranco Parati, Luis Ruilope, Philippe van de Borne, Costas Tsioufis, Society of Hypertension European Society of Hypertension

Research output: Contribution to journalArticle

Abstract

Out of the overall hypertensive population it is estimated that approximately 10% have treatment resistant hypertension (TRH). Percutaneous catheter-based transluminal renal ablation (renal denervation [RDN] by delivery of radiofrequency energy) has emerged as a new approach to achieve sustained blood pressure reduction in patients with TRH. This innovative interventional technique is now available across Europe for severe TRH for those patients in whom pharmacologic strategies and lifestyle changes have failed to control blood pressure below target (usually

Original languageEnglish
JournalEuroIntervention
Volume9 Suppl R
Publication statusPublished - May 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Updated ESH position paper on interventional therapy of resistant hypertension.'. Together they form a unique fingerprint.

  • Cite this

    Schmieder, R. E., Redon, J., Grassi, G., Kjeldsen, S. E., Mancia, G., Narkiewicz, K., Parati, G., Ruilope, L., van de Borne, P., Tsioufis, C., & European Society of Hypertension, S. O. H. (2013). Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention, 9 Suppl R.